Human Growth Hormone Drugs

World Market Report

MCP-7129

EXECUTIVE ENGAGEMENTS

POOL

2751
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

493
Interactions with Platform & by Email

PARTICIPANTS

83
Unique # Participated

VALIDATIONS

24
Responses Validated*

COMPANIES

46
Responses Validated*
* Login for a full stack data experience

DATE

OCT 2022

TABLES

189

PAGES

335

EDITION

17

PRICE

USD 5600

CODE

MCP-7129


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

RANK

(S/A/N/T)

%

VALIDATED RESEARCH *

* S = Strong; A = Active; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
RESEARCH MODULES EXECUTIVES
  

HIGHLIGHTS & REPORT INDEX

What`s New for 2022?

» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year

Global Human Growth Hormone Drugs Market to Reach $4.2 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Human Growth Hormone Drugs estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$4.2 Billion by 2027, growing at a CAGR of 3.5% over the analysis period 2020-2027. Subcutaneous, one of the segments analyzed in the report, is projected to record a 4% CAGR and reach US$2.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Intramuscular segment is readjusted to a revised 3.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 5.2% CAGR
The Human Growth Hormone Drugs market in the U.S. is estimated at US$1.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$299.1 Million by the year 2027 trailing a CAGR of 5.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 3.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.Intravenous Segment to Record 2.3% CAGR
In the global Intravenous segment, USA, Canada, Japan, China and Europe will drive the 2.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$231.8 Million in the year 2020 will reach a projected size of US$269.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

SELECT PLAYERS

AnkeBio Co. Ltd; Eli Lilly and Company; EMD Serono Inc.; Ferring Pharmaceuticals; Genentech, Inc (Roche); GeneScience Pharmaceuticals Co. Ltd; Ipsen S.A.; LG Life Sciences; Merck KGaA; Novo Nordisk A/S; Pfizer, Inc; Sandoz International GmbH (Novartis AG); Strongbridge Biopharma; Teva Pharmaceutical Industries, Ltd

SEGMENTS

» Route of Administration (Subcutaneous, Intramuscular, Intravenous, Oral) » Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy) » Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS), Other Applications)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Latin America » Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Human Growth Hormone Drugs – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
A Prelude to Human Growth Hormones
Recombinant Human Growth Hormones
Evolution of Recombinant Human Growth Hormones (hGH)
COVID-19 Impact on Human Growth Hormone Drugs
GLOBAL MARKET OVERVIEW
Global Human Growth Hormone Drugs Market to Witness Steady Growth
List of Select Approved Prescription Daily-dose hGH Products by Indication
List of Select Approved Prescription Weekly-dose hGH Products by Indication
Subcutaneous Route Dominates Human Growth Hormone Drugs Market
Growth Hormone Deficiency Application Leads the Human Growth Hormone Drugs Market
North America and Europe Dominate, Asia-Pacific to Witness Fastest Growth
Market Restraints
Competition
EXHIBIT: Leading Recombinant hGH Products in the Global Market (2020): Annual Sales in US$ Million for Genotropin, Humatrope, Norditropin, Nutropin and Saizen
EXHIBIT: Global Recombinant hGH Products Market (2020): Market Share of Leading Players
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
High Prevalence of Growth Hormone Deficiency Disorders
Pediatric GHD Rules, while Adult GHD Remains Underserved
EXHIBIT: Worldwide Recombinant Human Growth Hormone Market by Indication (2020): Percentage Breakdown of Value Sales for Pediatric GHD; Adult GHD, Turner Syndrome & Idiopathic Short Stature; and Others
Long-Acting hGH Drugs - A Game Changer for the Human Growth Hormone Drugs Market
Approval of Novo Nordisk’s Once-Weekly Sogroya to Transform the Market Landscape
Other Noteworthy Developments in the Long Acting hGH Space
Patent Expiry Paves Way for the Emergence of Biosimilars
Strong Innovation Drive Takes Hold of the hGH Industry
Manufacturers Bet on Novel Drug Delivery Technologies
Growing Non-Prescription/Off-Label Usage – A Potential Health Hazard
Needle-less Drug Delivery Systems to Wipe Out of Syringes
Drug Delivery Device Options for Marketed hGH Products
Major Growth Restraining Factors
Complex Delivery System
High Cost of hGH Treatment
Biosimilars Threaten Revenue Growth Erosion
PIPELINE ANALYSIS
Select Daily and Long-Acting Human Growth Hormone Products List in Phase III Pipeline
4. GLOBAL MARKET PERSPECTIVE
World Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Human Growth Hormone Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Human Growth Hormone Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Subcutaneous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Intramuscular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Intramuscular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Intramuscular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Intravenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Intravenous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Intravenous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Specialty Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Specialty Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Specialty Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Retail Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Online Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Growth Hormone Deficiency by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Growth Hormone Deficiency by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Growth Hormone Deficiency by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Turner Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Turner Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Turner Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Idiopathic Short Stature (ISS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Idiopathic Short Stature (ISS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Idiopathic Short Stature (ISS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Prader-Willi Syndrome (PWS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Prader-Willi Syndrome (PWS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Prader-Willi Syndrome (PWS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
UNITED STATES
Human Growth Hormone Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
USA Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
USA Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
CANADA
Canada Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Canada Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
JAPAN
Human Growth Hormone Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Japan Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Japan Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
CHINA
Human Growth Hormone Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
China Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
China Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
EUROPE
Human Growth Hormone Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Europe Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Human Growth Hormone Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Human Growth Hormone Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Europe Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
FRANCE
Human Growth Hormone Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
France Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
France Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
GERMANY
Human Growth Hormone Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Germany Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Germany Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
ITALY
Italy Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Italy Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
UNITED KINGDOM
Human Growth Hormone Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
UK Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
UK Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
SPAIN
Spain Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Spain Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
RUSSIA
Russia Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Russia Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Rest of Europe Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Human Growth Hormone Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Asia-Pacific Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
LATIN AMERICA
Human Growth Hormone Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
Latin America Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Latin America Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
MIDDLE EAST
Human Growth Hormone Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
Middle East Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Middle East Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027
AFRICA
Human Growth Hormone Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
Africa Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Human Growth Hormone Drugs by Route Of Administration - Subcutaneous, Intramuscular, Intravenous and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Human Growth Hormone Drugs by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intravenous and Oral for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Human Growth Hormone Drugs by Distribution Channel - Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Human Growth Hormone Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy and Online Pharmacy for the Years 2012, 2021 & 2027
Africa Recent Past, Current & Future Analysis for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Human Growth Hormone Drugs by Application - Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Human Growth Hormone Drugs by Application - Percentage Breakdown of Value Sales for Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS) and Other Applications for the Years 2012, 2021 & 2027

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com